DNase is a prognostic marker in liver cancer patients receiving transarterial chemoembolization therapy

Int J Clin Pharmacol Ther. 2013 Jan;51(1):80-3. doi: 10.5414/cpp51080.
No abstract available

MeSH terms

  • Aged
  • Biomarkers, Tumor / blood*
  • Chemoembolization, Therapeutic / methods*
  • Deoxyribonucleases / blood*
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Follow-Up Studies
  • HMGB1 Protein / blood
  • Humans
  • Kaplan-Meier Estimate
  • Liver Neoplasms / blood*
  • Liver Neoplasms / therapy*
  • Male
  • Prospective Studies
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • HMGB1 Protein
  • Deoxyribonucleases